X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (135) 135
Publication (20) 20
Patent (12) 12
Book Chapter (8) 8
Book Review (3) 3
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
endocrinology & metabolism (60) 60
index medicus (45) 45
male (29) 29
female (28) 28
middle aged (24) 24
aged (22) 22
diagnosis (20) 20
adult (19) 19
pituitary (19) 19
abridged index medicus (15) 15
cortisol (14) 14
cushing syndrome - diagnosis (13) 13
dexamethasone (13) 13
acth (12) 12
human necessities (12) 12
hydrocortisone - blood (12) 12
hygiene (12) 12
medical or veterinary science (12) 12
preparations for medical, dental, or toilet purposes (12) 12
adrenal (10) 10
cushing syndrome (10) 10
hydrocortisone (10) 10
management (10) 10
patients (10) 10
adolescent (9) 9
adrenocorticotropic hormone - blood (9) 9
cushing's syndrome (9) 9
disease (9) 9
secretion (9) 9
aged, 80 and over (8) 8
diagnosis, differential (8) 8
glucocorticoids (8) 8
mortality (8) 8
retrospective studies (8) 8
somatostatin - analogs & derivatives (8) 8
urinary free cortisol (8) 8
young adult (8) 8
analysis (7) 7
dexamethasone-suppression test (7) 7
differential-diagnosis (7) 7
hydrocortisone - urine (7) 7
medicine, general & internal (7) 7
treatment outcome (7) 7
adrenocorticotrophic hormone (6) 6
adrenocorticotropic hormone (6) 6
child (6) 6
corticosteroids (6) 6
cushing's disease (6) 6
diabetes (6) 6
endocrinology (6) 6
pasireotide (6) 6
quality-of-life (6) 6
risk factors (6) 6
subclinical cushings-syndrome (6) 6
adenoma (5) 5
adrenal glands (5) 5
care and treatment (5) 5
corticotropin-releasing hormone (5) 5
cushing syndrome - etiology (5) 5
double-blind method (5) 5
hormones (5) 5
hypercortisolism (5) 5
medical therapy (5) 5
nervous system diseases (5) 5
pituitary acth hypersecretion - drug therapy (5) 5
somatostatin - therapeutic use (5) 5
surgery (5) 5
tomography, x-ray computed (5) 5
tumors (5) 5
acromegaly (4) 4
adenoma - diagnosis (4) 4
adenomas (4) 4
adrenal gland neoplasms - diagnosis (4) 4
adrenalectomy (4) 4
biomarkers - blood (4) 4
cardiovascular risk (4) 4
circadian rhythm (4) 4
cross-sectional studies (4) 4
cushing syndrome - drug therapy (4) 4
cushings-syndrome (4) 4
dose-response relationship, drug (4) 4
ectopic (4) 4
genetics (4) 4
hydrocortisone - analysis (4) 4
hyperglycemia (4) 4
hypertension (4) 4
morbidity (4) 4
neuroendocrine tumors (4) 4
night salivary cortisol (4) 4
prospective studies (4) 4
saliva - chemistry (4) 4
salivary cortisol (4) 4
specific therapeutic activity of chemical compounds ormedicinal preparations (4) 4
term-follow-up (4) 4
time factors (4) 4
acromegaly - drug therapy (3) 3
addisons-disease (3) 3
adenoma - complications (3) 3
adrenal cortex function tests (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Endocrinology, ISSN 1759-5029, 09/2016, Volume 12, Issue 9, pp. 502 - 503
A recent study by Clayton et al. shows that overall mortality is increased for patients with Cushing disease, even in remission, but that mortality is normal... 
Relapse | Mortality | Analysis | Risk factors | Cushing syndrome | Diseases
Journal Article
Clinical Endocrinology, ISSN 0300-0664, 01/2019, Volume 90, Issue 1, pp. 114 - 121
Objective Transsphenoidal surgery (TSS) remains the recommended primary treatment for acromegaly. Long-term outcome data are not available for patients treated... 
pituitary adenomas | acromegaly | hypopituitarism | growth hormone | IGF1 | radiosurgery | morbidity | GAMMA-KNIFE RADIOSURGERY | PITUITARY-ADENOMAS | STEREOTACTIC RADIOSURGERY | GROWTH-HORMONE | ENDOCRINOLOGY & METABOLISM | RADIOTHERAPY | Short tandem repeats | Magnetic resonance imaging | Hypopituitarism | Insulin-like growth factor I | Surgery | Acromegaly | Growth hormone | Patients | Morbidity | Latency
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 10/2019
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 06/2015, Volume 172, Issue 6, pp. R263 - R280
Steroidogenesis enzyme inhibitors are the mainstay of medical therapy in Cushing's syndrome (CS). Ketoconazole (KTZ) and metyrapone are the most commonly used... 
LONG-TERM MANAGEMENT | ADRENAL STEROIDOGENESIS | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | ALDOSTERONE SYNTHASE INHIBITION | ADRENOCORTICAL CARCINOMA | MULTIPLE TRAUMA PATIENTS | LOW-DOSE ETOMIDATE | OF-THE-LITERATURE | CRITICALLY-ILL PATIENTS | IDEAL INDUCTION AGENT
Journal Article
by Valassi, Elena and Feelders, Richard and Maiter, Dominique and Chanson, Philippe and Yaneva, Maria and Reincke, Martin and Krsek, Michal and Tóth, Miklós and Webb, Susan M and Santos, Alicia and Paiva, Isabel and Komerdus, Irina and Droste, Michael and Tabarin, Antoine and Strasburger, Christian J and Franz, Holger and Trainer, Peter J and Newell‐Price, John and Wass, John AH and Papakokkinou, Eleni and Ragnarsson, Oskar and Ambrogio, A and Aranda, G and Arosio, M and Balomenaki, M and Beck‐Peccoz, P and Berr‐Kirmair, C and Bolanowski, M and Bollerslev, J and Thierry, B and Carvalho, D and Cavagnini, F and Christ, E and Demtröder, F and Denes, J and Dimopoulou, C and Dreval, A and Dusek, T and Erdinc, E and Evang, JA and Fazel, J and Fica, S and Ghigo, E and Goth, M and Greenman, Y and Greisa, V and Halperin, I and Hanzu, FA and Hermus, A and Johannsson, G and Kamenicky, P and Kasperlik‐Zaluska, A and Kirchner, J and Darko, K and Kraljevic, I and Kruszynska, A and Lambrescu, I and Lang, S and Luger, A and Marpole, N and Martin, S and Martinie, M and Moros, O and Orbetzova, M and Pecori Giraldi, F and Pereira, AM and Pickel, J and Pirags, V and Reghina, AD and Roberts, M and Roerink, S and Roig, O and Rowan, C and Rudenko, P and Sahnoun, MA and Salvador, J and Sigurjonsdottir, HA and Skoric Polovina, T and Smith, R and Stachowska, B and Stalla, G and Tőke, J and Ubina, E and Vinay, S and Wagenmakers, M and Werner, S and Young, J and Zdunowski, P and Zopf, K and Zopp, S and Zosin, I and ERCUSYN Study Grp and ERCUSYN Study Group and the ERCUSYN Study Group and Sahlgrenska akademin and Institute of Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för medicin
Clinical Endocrinology, ISSN 0300-0664, 06/2018, Volume 88, Issue 6, pp. 787 - 798
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 09/2016, Volume 12, Issue 9, pp. 502 - 503
A recent study by Clayton et al. shows that overall mortality is increased for patients with Cushing disease, even in remission, but that mortality is normal... 
ENDOCRINOLOGY & METABOLISM | REMISSION | Pituitary Neoplasms | Pituitary ACTH Hypersecretion | Cushing Syndrome | Pituitary Gland | Humans
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2009, Volume 23, Issue 1, pp. S5 - S14
Endogenous Cushing's syndrome is an uncommon endocrine disorder that can often prove challenging, for both initial diagnosis and subsequent differential... 
Endocrinology & Metabolism | pituitary | Cushing's syndrome | adrenocorticotrophic hormone (ACTH) | Cushing's disease | ACTH | Cushing syndrome | Diagnosis
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 09/2015, Volume 9, pp. 5075 - 5086
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release (pasireotide LAR) with octreotide long-acting repeatable... 
Somatostatin analogues | Pasireotide | Symptom control | Progression-free survival | Carcinoid syndrome | Neuroendocrine tumors | CONSENSUS GUIDELINES | SOM230 | CHEMISTRY, MEDICINAL | MANAGEMENT | pasireotide | symptom control | progression-free survival | PHARMACOLOGY & PHARMACY | carcinoid syndrome | somatostatin analogues | neuroendocrine tumors | Digestive System Neoplasms - mortality | Somatostatin - adverse effects | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Digestive System Neoplasms - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Digestive System Neoplasms - pathology | Aged, 80 and over | Adult | Female | Odds Ratio | Somatostatin - analogs & derivatives | Double-Blind Method | Carcinoid Tumor - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Tumor Burden | Octreotide - therapeutic use | Carcinoid Tumor - secondary | Disease-Free Survival | Aged | Somatostatin - therapeutic use | Carcinoid Tumor - mortality | Drug Substitution | Delayed-Action Preparations | Controlled release technology | Testing | Signs and symptoms | Statistical analysis | Diarrhea | Oncology | Octreotide | Nausea | Metastasis | Cancer therapies | Patients | Metastases | Confidence intervals | Refractory materials | Hyperglycemia | Hospitals | Intestine | Diabetes | Somatostatin | Digestive tract | Drug dosages | Predictive control | Tumors | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
by Hernández-Ramírez, Laura C and Gabrovska, Plamena and Dénes, Judit and Stals, Karen and Trivellin, Giampaolo and Tilley, Daniel and Ferraù, Francesco and Evanson, Jane and Ellard, Sian and Grossman, Ashley B and Roncaroli, Federico and Gadelha, Mônica R and Korbonits, Márta and Agha, Amar and Akker, Scott A and Aflorei, Elena D and Alföldi, Sándor and Arlt, Wiebke and Atkinson, Brew and Aulinas-Masó, Anna and Aylwin, Simon J and Backeljauw, Philippe F and Badiu, Corin and Baldeweg, Stephanie and Bano, Gul and Barkan, Ariel and Barwell, Julian and Bernal-González, Carmen and Besser, G. Michael and Bevan, John S and Blair, Jo and Bouloux, Pierre and Bradley, Lisa and Buchfelder, Michael and Cakir, Mehtap and Canham, Natalie and Carroll, Paul and Chahal, Harvinder S and Cheetham, Tim and Chentli, Farida and Clayton, Richard N and Cohen, Mark and Cole, Trevor and Courtney, Hamish and Crowne, Elizabeth and Cuthbertson, Daniel and Dal, Jacob and Dalantaeva, Nadezhda and Daousi, Christina and Darzy, Ken and Dattani, Mehul and Davies, Justin H and Davis, Julian and De Castro, Margaret and De Marinis, Laura and Drake, William and Dutta, Pinaki and Dzeranova, Larisa and Edén-Engström, Britt and Eeles, Rosalind and Elfving, Maria and Elston, Marianne and Emmerson, Louise and Fersht, Naomi and Fica, Simona and Fischli, Stefan and Flanagan, Daniel and Fleseriu, Maria and Freda, Pamela U and Friedman, Theodore and Frohman, Lawrence A and Gallego, Patricia and Gevers, Evelien and Gláz, Edit and Goldman, James A and Goldstone, Anthony P and Goth, Miklos and Greenhalgh, Lynn and Grieve, Joan and Guitelman, Mirtha and Gürlek, Alper and Gurnell, Mark and Horvath, Katalin and Howlett, Trevor A and Höybye, Charlotte and Hunter, Steven and Iacovazzo, Donato and Igaz, Peter and Inder, Warrick J and Iwata, Takeo and Izatt, Louise and Jagadeesh, Sujatha and Kaltsas, Gregory and Kaplan, Felicity and Karavitaki, Niki and Kastelan, Darko and Katz, Michelle and Kearney, Tara and Khoo, Bernard and Kiraly-Borri, Cathy and ... and Int FIPA Consortium and International FIPA Consortium
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 09/2015, Volume 100, Issue 9, pp. E1242 - E1254
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 10, pp. 914 - 924
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 02/2006, Volume 91, Issue 2, pp. 371 - 377
Journal Article